Skip to main content
Monday, November 16, 2026Nov 16

Drug executives: Big jump in vaccine supply is coming soon

In this Jan. 22, 2021, file photo, certified medical assistants Martha Sida, from left, Tina Killebrew and Cynthia Bernal prepare doses of the Pfizer-BioNTech COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas, in Las Vegas. COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month. The companies insisted Tuesday, Feb. 23, at a hearing that they will be able to provide enough vaccine for most Americans by summer. (AP Photo/John Locher)
In this Jan. 22, 2021, file photo, certified medical assistants Martha Sida, from left, Tina Killebrew and Cynthia Bernal prepare doses of the Pfizer-BioNTech COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas, in Las Vegas. COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month. The companies insisted Tuesday, Feb. 23, at a hearing that they will be able to provide enough vaccine for most Americans by summer. (AP Photo/John Locher)

WASHINGTON (AP) – COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist they will be able to provide enough for most Americans to get inoculated by summer.

By the end of March, Pfizer and Moderna expect to have provided the U.S. government with a total of 220 million vaccine doses, up sharply from the roughly 75 million shipped so far.

“We do believe we’re on track,” Moderna President Stephen Hoge said, outlining ways the company has ramped up production. “We think we’re at a very good spot.”

That’s not counting a third vaccine, from Johnson & Johnson, that’s expected to get a green light from regulators soon. The Biden administration said Tuesday that it expects about 2 million doses of that vaccine to be shipped in the first week, but the company told lawmakers it should provide enough of the single-dose option for 20 million people by the end of March.

Looking ahead to summer, Pfizer and Moderna expect to complete delivery of 300 million doses each, and J&J aims to provide an additional 100 million doses. That would be more than enough to vaccinate every American adult, the goal set by the Biden administration.